Bacitracin
FDA Label NDC 50382-005

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Galentic Pharma (india) Priva Te Limited for the product Bacitracin (NDC 50382-005). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, purpose:, warnings:, dosage and administration, indications and usage, stop use and ask a doctor if:, do not use if:, keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Active Ingredient

Active ingredient               Purpose
Bacitracin 500 Units                Antibiotic

Purpose:

First aid to help prevent infection.

Warnings:

For external use only

Dosage And Administration

Directions:

  • clean the affected areas
  • apply a small amount of product (an amountb equal to the surface area of the tip of the finger) on the area 1 to 3 times daily.
  • may be covered with a sterile bandage

Indications And Usage

First aid to help prevent infection in:

  • minor cuts
  • scrapes
  • burns

Stop Use And Ask A Doctor If:

  • the condition persists or gets worse, or if a rash or other allergic reaction develops.

Do Not Use If:

  • if you are allergic to any of the ingredients
  • in the eyes
  • over large areas of the body
  • longer than 1 week unless directed by a doctor

Keep Out Of Reach Of Children

if swallowed, get medical help or contact a Poison Control Center right away

Ask A Doctor Before Use:

  • in case of deep or puncture wounds
  • animal bites
  • serious burns

Other Information

  • store at controlled room temperature 15°-30° C (59°-86° F)

Inactive Ingredients

Light Mineral Oil, White Petrolatum

Principal Display Panel

Bacitracin Ointment:

Gal Bacitracin.jpg

* Please review the disclaimer below.